ResourceLife Sciences
Challenges in laboratory detection of the α3.7 and α4.2 deletion in thalassemia
8 May 2025Examine the diagnostic challenges of detecting the α3.7 and α4.2 deletions in alpha thalassemia, a complex and widespread genetic blood disorder. Explore the limitations of traditional methods such as PCR and MLPA, and learn how next-generation sequencing (NGS) is a more accurate and scalable alternative. Plus, discover how integrated bioinformatics tools are improving the accessibility and efficiency of genetic testing for thalassemia.
Links
Tags
Next Generation SequencingNext-generation sequencing (NGS), also known as whole-genome sequencing, high-throughput sequencing and massive parallel sequencing, produces and analyses thousands to millions of nucleotide sequences at once. Sequencing systems operate via varying technologies depending on the manufacturer, including sequencing by synthesis, ligation, pyrosequencing, ion semiconductor and single-molecule real-time sequencing. For NGS, library preparation is paramount to successful sequencing. In this section, explore a range of library preparation kits, from targeted, amplicon-based or hybridization-based kits including epigenomic, transcriptomic and genomic workflows to fragmentation kits. Find the best next-generation sequencing products in our peer-reviewed product directory: compare products, check customer reviews and receive pricing direct from manufacturers.Molecular DiagnosticsMolecular diagnostics use an individual’s genetic code and gene expression to diagnose and monitor diseases. The technique is used increasingly in the field of infectious diseases and oncology, as well as areas such as coagulation, HLA typing and pharmacogenomics. Molecular diagnostics plays a pivotal role in personalized medicine.Genetic Testing